Publications by Zheng, Mingjun

2020

Hu, Yuexin; Zheng, Mingjun; Wang, Caixia; Wang, Shuang; Gou, Rui; Liu, Ouxuan; Li, Xiao; Liu, Juanjuan; Lin, Bei (2020): Identification of KIF23 as a prognostic signature for ovarian cancer based on large-scale sampling and clinical validation. In: American Journal of Translational Research, Vol. 12, No. 9: pp. 4955-4976

Zheng, Mingjun; Hu, Yuexin; Gou, Rui; Nie, Xin; Li, Xiao; Liu, Juanjuan; Lin, Bei (2020): Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation. In: Biomedicine & Pharmacotherapy, Vol. 124, 109810

Zheng, Mingjun; Hu, Yuexin; Gou, Rui; Liu, Ouxuan; Nie, Xin; Li, Xiao; Liu, Qing; Hao, Yingying; Liu, Juanjuan; Lin, Bei (2020): Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma. In: Journal of Cellular and Molecular Medicine, Vol. 24, No. 5: pp. 2819-2831

Zou, Ruoyao; Zheng, Mingjun; Tan, Mingzi; Xu, Haoya; Luan, Nannan; Zhu, Liancheng (2020): Decreased PTGDS Expression Predicting Poor Survival of Endometrial Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Immunohistochemical Validation. In: Cancer Management and Research, Vol. 12: pp. 5057-5075

Kong, Lingming; Liu, Peng; Zheng, Mingjun; Wang, Zhongpeng; Gao, Yang; Liang, Keke; Wang, Huaitao; Tan, Xiaodong (2020): The miR-1224-5p/ELF3 Axis Regulates Malignant Behaviors of Pancreatic Cancer via PI3K/AKT/Notch Signaling Pathways. In: Oncotargets and Therapy, Vol. 13: pp. 3449-3466 [PDF, 17MB]

Kong, Lingming; Liu, Peng; Zheng, Mingjun; Xue, Busheng; Liang, Keke; Tan, Xiaodong (2020): Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer. In: Epigenomics, Vol. 12, No. 6: pp. 507-524

Zheng, Mingjun; Mullikin, Heather; Hester, Anna; Czogalla, Bastian; Heidegger, Helene; Vilsmaier, Theresa; Vattai, Aurelia; Chelariu-Raicu, Anca; Jeschke, Udo; Trillsch, Fabian; Mahner, Sven; Kaltofen, Till (2020): Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile. In: International Journal of Molecular Sciences, Vol. 21, No. 23, 9169